Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Discover the full record of transactions filed by Norwalk Leslie V, Director. Director active across 8 companies, notably Neurocrine Biosciences INC. In total, 30 reports have been recorded. Split: 0 buy · 6 sells. Total volume traded: €1.7m. History available since 1 June 2021. The latest transaction was disclosed on 28 July 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Norwalk Leslie V
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
381,005 títulos@ 82,02 US$0.0001% mcap100.0% de su flujoCommon StockSEC:0001071739-22-000147:0
25 de 30 declaraciones
About Norwalk Leslie V
Norwalk Leslie V is a Director with 28 filings in total. Across the 28 recent filings available, the recorded sell volume is EUR 1549432, with a date range from 2021-06-03 to 2026-06-26, and the top filings involve Neurocrine Biosciences INC and Globus Medical INC.